BRIEF-Spero Therapeutics to acquire worldwide rights to Vertex's VXC-486/VXC-100
May 25, 2016 at 08:20 AM EDT
* Deal to acquire worldwide rights to VXC-486/VXC-100 and a portfolio of innovative antibacterial compounds
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.